| Antonia Lynn Mcclune, DPM | |
|
1501 Ne Medical Center Dr, Bend, OR 97701-6051 | |
| (541) 382-4900 | |
| Not Available |
| Full Name | Antonia Lynn Mcclune |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 13 Years |
| Location | 1501 Ne Medical Center Dr, Bend, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285923714 | NPI | - | NPPES |
| 500677212 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | DP169491 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| St Charles Prineville | Prineville, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bend Memorial Clinic Pc | 7214936533 | 201 |
News Archive
The work of a team of scientists at Cold Spring Harbor Laboratory (CSHL) led by Professor Nicholas Tonks FRS, suggests a way to overcome one of the major technical obstacles preventing a leading therapeutic target for diabetes and obesity from being addressed successfully by novel drugs.
A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.
As we learn and develop, our neurons change. They make new pathways and connections as our brain processes new information. In order to do this, individual neurons use an internal gauge to maintain a delicate balance that keeps our brains from becoming too excitable.
New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.
Biologists have long known that an enzyme called the PI 3-kinase is a crucial actor in the main molecular pathway for insulin signaling in cells. Researchers at Joslin Diabetes Center now have uncovered startling evidence that one of the proteins in this enzyme also drives a pathway with an opposite result-triggering a stress response that leads to insulin resistance.
› Verified 4 days ago
| Provider Name | Portland Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1558379099 PECOS PAC ID: 8224942867 Enrollment ID: O20031118000101 |
News Archive
The work of a team of scientists at Cold Spring Harbor Laboratory (CSHL) led by Professor Nicholas Tonks FRS, suggests a way to overcome one of the major technical obstacles preventing a leading therapeutic target for diabetes and obesity from being addressed successfully by novel drugs.
A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.
As we learn and develop, our neurons change. They make new pathways and connections as our brain processes new information. In order to do this, individual neurons use an internal gauge to maintain a delicate balance that keeps our brains from becoming too excitable.
New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.
Biologists have long known that an enzyme called the PI 3-kinase is a crucial actor in the main molecular pathway for insulin signaling in cells. Researchers at Joslin Diabetes Center now have uncovered startling evidence that one of the proteins in this enzyme also drives a pathway with an opposite result-triggering a stress response that leads to insulin resistance.
› Verified 4 days ago
| Provider Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
The work of a team of scientists at Cold Spring Harbor Laboratory (CSHL) led by Professor Nicholas Tonks FRS, suggests a way to overcome one of the major technical obstacles preventing a leading therapeutic target for diabetes and obesity from being addressed successfully by novel drugs.
A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.
As we learn and develop, our neurons change. They make new pathways and connections as our brain processes new information. In order to do this, individual neurons use an internal gauge to maintain a delicate balance that keeps our brains from becoming too excitable.
New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.
Biologists have long known that an enzyme called the PI 3-kinase is a crucial actor in the main molecular pathway for insulin signaling in cells. Researchers at Joslin Diabetes Center now have uncovered startling evidence that one of the proteins in this enzyme also drives a pathway with an opposite result-triggering a stress response that leads to insulin resistance.
› Verified 4 days ago
| Provider Name | Bend Memorial Clinic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1699827477 PECOS PAC ID: 7214936533 Enrollment ID: O20061215000022 |
News Archive
The work of a team of scientists at Cold Spring Harbor Laboratory (CSHL) led by Professor Nicholas Tonks FRS, suggests a way to overcome one of the major technical obstacles preventing a leading therapeutic target for diabetes and obesity from being addressed successfully by novel drugs.
A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.
As we learn and develop, our neurons change. They make new pathways and connections as our brain processes new information. In order to do this, individual neurons use an internal gauge to maintain a delicate balance that keeps our brains from becoming too excitable.
New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.
Biologists have long known that an enzyme called the PI 3-kinase is a crucial actor in the main molecular pathway for insulin signaling in cells. Researchers at Joslin Diabetes Center now have uncovered startling evidence that one of the proteins in this enzyme also drives a pathway with an opposite result-triggering a stress response that leads to insulin resistance.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Antonia Lynn Mcclune, DPM Po Box 6048, Bend, OR 97708-6048 Ph: (541) 382-4900 | Antonia Lynn Mcclune, DPM 1501 Ne Medical Center Dr, Bend, OR 97701-6051 Ph: (541) 382-4900 |
News Archive
The work of a team of scientists at Cold Spring Harbor Laboratory (CSHL) led by Professor Nicholas Tonks FRS, suggests a way to overcome one of the major technical obstacles preventing a leading therapeutic target for diabetes and obesity from being addressed successfully by novel drugs.
A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.
As we learn and develop, our neurons change. They make new pathways and connections as our brain processes new information. In order to do this, individual neurons use an internal gauge to maintain a delicate balance that keeps our brains from becoming too excitable.
New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.
Biologists have long known that an enzyme called the PI 3-kinase is a crucial actor in the main molecular pathway for insulin signaling in cells. Researchers at Joslin Diabetes Center now have uncovered startling evidence that one of the proteins in this enzyme also drives a pathway with an opposite result-triggering a stress response that leads to insulin resistance.
› Verified 4 days ago
Dr. Amanda Westfall Mccarty, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1693 Sw Chandler Ave, Suite 280, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Northwest Footcare, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1693 Sw Chandler Ave, Ste 280, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Dr. Laura Schweger Savage, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1506 Ne Williamson Blvd, Bend, OR 97701 Phone: 541-383-3668 Fax: 541-383-4546 | |
Tajyant Nat Chotechuang, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1510 Sw Nancy Way Ste 2, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Bryan Wilhelm, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1510 Sw Nancy Way Ste 2, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Dr. Frank Robert Cobarrubia, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1510 Sw Nancy Way Ste 2, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 |